PSIX(PSIX)
PSIX
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $673M | $815M | $1.03B | $1.43B |
| Low | $658M | $775M | $1.03B | $1.38B |
| High | $693M | $853M | $1.03B | $1.49B |
| EBITDA Avg | $103M | $132M | $191M | $413M |
| Low | $99M | $126M | $173M | $394M |
| High | $107M | $137M | $208M | $433M |
| EBIT Avg | $97M | $126M | $184M | $406M |
| Low | $93M | $120M | $167M | $387M |
| High | $101M | $131M | $201M | $425M |
| Net Income Avg | $68M | $90M | $136M | $311M |
| Low | $64M | $86M | $123M | $296M |
| High | $71M | $95M | $150M | $327M |
| EPS Avg | $2.93 | $3.90 | $5.91 | $13.49 |
| Low | $2.79 | $3.72 | $5.32 | $12.84 |
| High | $3.07 | $4.10 | $6.50 | $14.17 |
| Analysts (Rev / EPS) | 3 / 2 | 3 / 2 | 2 / 2 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $200M | $200M | $171M | $202M | $215M | $214M |
| Low | $189M | $199M | $166M | $196M | $209M | $208M |
| High | $211M | $201M | $176M | $208M | $221M | $221M |
| EBITDA Avg | $32M | $31M | $23M | $28M | $33M | $34M |
| Low | $31M | $30M | $22M | $27M | $32M | $33M |
| High | $33M | $32M | $23M | $29M | $34M | $35M |
| EBIT Avg | $29M | $27M | $19M | $25M | $30M | $31M |
| Low | $28M | $26M | $19M | $24M | $29M | $30M |
| High | $30M | $28M | $20M | $26M | $31M | $32M |
| Net Income Avg | $21M | $20M | $14M | $19M | $23M | $23M |
| Low | $21M | $20M | $14M | $18M | $22M | $22M |
| High | $22M | $21M | $15M | $19M | $23M | $24M |
| EPS Avg | $0.93 | $0.89 | $0.61 | $0.81 | $0.98 | $1.01 |
| Low | $0.89 | $0.85 | $0.59 | $0.78 | $0.94 | $0.97 |
| High | $0.96 | $0.92 | $0.63 | $0.84 | $1.02 | $1.05 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |